Royal Bank Of Canada Aquestive Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 341,419 shares of AQST stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341,419
Previous 4,984
6750.3%
Holding current value
$1.76 Million
Previous $14,000
7971.43%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AQST
# of Institutions
125Shares Held
47.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$50.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$28.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$22.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$15.3 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$11.3 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $275M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...